NewsWhore
08-29-2010, 02:50 PM
STOCKHOLM (Reuters) - AstraZeneca's new blood-thinning drug Brilinta has been given a class 1 recommendation as a treatment option under European medical guidelines, even though it has yet to be appro...
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/38196545/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/38196545/)